Phenotypic and functional changes of cytotoxic CD56pos natural T cells determine outcome of acute hepatitis C virus infection

Journal of Virology

Volumn 81, Issue 17, 2007, Pages 9292-9298

  Golden Mason, Lucy ^a   Castelblanco, Nicole ^a   O'Farrelly, Cliona ^b   Rosen, Hugo R ^a,c  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^c Research Bridge   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD158A ANTIGEN; CD56 ANTIGEN; CELL SURFACE RECEPTOR; INTERLEUKIN 13; INTERLEUKIN 2; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2A; UNCLASSIFIED DRUG; VIRUS RNA;

ADULT; ANIMAL CELL; ARTICLE; CELL KILLING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; FEMALE; GENE EXPRESSION; HEPATITIS C; HUMAN; IMMUNOREGULATION; INNATE IMMUNITY; MALE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; T LYMPHOCYTE ACTIVATION;

ACUTE DISEASE; ADULT; ANTIGENS, CD56; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERLEUKIN-13; INTERLEUKIN-2; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; RECEPTORS, IMMUNOLOGIC; RNA, VIRAL; T-LYMPHOCYTE SUBSETS; VIRAL LOAD;

HEPATITIS C VIRUS;

EID: 34548169289     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00834-07     Document Type: Article

References (38)

1. Alter, M. J. 1997. Epidemiology of hepatitis C. Hepatology 26:62S-65S.
2. Bailer, R. T., A. Holloway, J. Sun, J. B. Margolick, M. Martin, J. Kostman, and L. J. Montaner. 1999. IL-13 and IFN-gamma secretion by activated T cells in HIV-1 infection associated with viral suppression and a lack of disease progression. J. Immunol. 162:7534-7542.
3. Biron, C. A., K. B. Nguyen, and G. C. Pien. 2002. Innate immune responses to LCMV infections: natural killer cells and cytokines. Curr. Top. Microbiol. Immunol. 263:7-27.
4. Bowen, D. G., and C. M. Walker. 2005. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 436:946-952.
5. Brenner, B. G., M. Gornitsky, and M. A. Wainberg. 1994. Interleukin-2-inducible natural immune (lymphokine-activated killer cell) responses as a functional correlate of progression to AIDS. Clin. Diagn. Lab. Immunol. 1:538-544.
6. Byers, A. M., N. P. Andrews, and A. E. Lukacher. 2006. CD94/NKG2A expression is associated with proliferative potential of CD8 T cells during persistent polyoma virus infection. J. Immunol. 176:6121-6129.
7. Cohen, J. 1999. The scientific challenge of hepatitis C. Science 285:26-30.
8. Colonna, M., C. Dohring, J. Samaridis, D. Scheidegger, M. Dessing, M. Cella, and K. S. Campbell. 1996. Human killer inhibitory receptors: specificity for HLA-class I molecules and mechanisms of signal transduction. Transpl. Proc. 28:3035.
9. Deignan, T., M. P. Curry, D. G. Doherty, L. Golden-Mason, Y. Volkov, S. Norris, N. Nolan, O. Traynor, G. McEntee, J. E. Hegarty, and C. O'Farrelly. 2002. Decrease in hepatic CD56(+) T cells and V alpha 24(+) natural killer T cells in chronic hepatitis C viral infection. J. Hepatol. 37:101-108.
10. De Maria, A., M. Fogli, S. Mazza, M. Basso, A. Picciotto, P. Costa, S. Congia, M. C. Mingari, and L. Moretta. 2007. Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients. Eur. J. Immunol. 37:445-455.
11. De Maria, A., M. Fogli, P. Costa, G. Murdaca, F. Puppo, D. Mavilio, A. Moretta, and L. Moretta. 2003. The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44). Eur. J. Immunol. 33:2410-2418.
12. Doherty, D. G., and C. O'Farrelly. 2000. Innate and adaptive lymphoid cells in the human liver. Immunol. Rev. 174:5-20.
13. Durante-Mangoni, E., R. Wang, A. Shaulov, Q. He, I. Nasser, N. Afdhal, M. J. Koziel, and M. A. Exley. 2004. Hepatic CD1d expression in hepatitis C virus infection and recognition by resident proinflammatory CD1d-reactive T cells. J. Immunol. 173:2159-2166.
14. Golden-Mason, L., and H. R. Rosen. 2006. Natural killer cells: primary target for hepatitis C virus immune evasion strategies? Liver Transpl. 12:363-372.
15. Guma, M., C. Cabrera, I. Erkizia, M. Bofill, B. Clotet, L. Ruiz, and M. Lopez-Botet. 2006. Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients. J. Infect. Dis. 194:38-41.
16. Jacobs, R., K. Weber, K. Wendt, H. Heiken, and R. E. Schmidt. 2004. Altered coexpression of lectin-like receptors CD94 and CD161 on NK and T cells in HIV patients. J. Clin. Immunol. 24:281-286.
17. Jinushi, M., T. Takehara, T. Tatsumi, T. Kanto, T. Miyagi, T. Suzuki, Y. Kanazawa, N. Hiramatsu, and N. Hayashi. 2004. Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection. J. Immunol. 173:6072-6081.
18. Kanto, T., and N. Hayashi. 2006. Immunopathogenesis of hepatitis C virus infection: multifaceted strategies subverting innate and adaptive immunity. Intern. Med. 45:183-191.
19. Kawarabayashi, N., S. Seki, K. Hatsuse, T. Ohkawa, Y. Koike, T. Aihara, Y. Habu, R. Nakagawa, K. Ami, H. Hiraide, and H. Mochizuki. 2000. Decrease of CD56(+)T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma. Hepatology 32:962-969.
20. Kelly-Rogers, J., L. Madrigal-Estebas, T. O'Connor, and D. G. Doherty. 2006. Activation-induced expression of CD56 by T cells is associated with a reprogramming of cytolytic activity and cytokine secretion profile in vitro. Hum. Immunol. 67:863-873.
21. Kronenberg, M. 2005. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23:877-900.
22. Lama, V. N., H. Harada, L. N. Badri, A. Flint, C. M. Hogaboam, A. McKenzie, F. J. Martinez, G. B. Toews, B. B. Moore, and D. J. Pinsky. 2006. Obligatory role for interleukin-13 in obstructive lesion development in airway allografts. Am. J. Pathol. 169:47-60.
23. Lanier, L. L. 2005. NK cell recognition. Annu. Rev. Immunol. 23:225-274.
24. Lanier, L. L., B. Corliss, J. Wu, and J. H. Phillips. 1998. Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity 8:693-701.
25. Li, Y., T. Zhang, C. Ho, J. S. Orange, S. D. Douglas, and W. Z. Ho. 2004. Natural killer cells inhibit hepatitis C virus expression. J. Leukoc. Biol. 76:1171-1179.
26. Mingari, M. C., G. Pietra, and L. Moretta. 2005. Human cytolytic T lymphocytes expressing HLA class-I-specific inhibitory receptors. Curr. Opin. Immunol. 17:312-319.
27. Moretta, A., C. Bottino, M. Vitale, D. Pende, C. Cantoni, M. C. Mingari, R. Biassoni, and L. Moretta. 2001. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19:197-223.
28. Moser, J. M., J. Gibbs, P. E. Jensen, and A. E. Lukacher. 2002. CD94-NKG2A receptors regulate antiviral CD8(+) T cell responses. Nat. Immunol. 3:189-195.
29. Nattermann, J., G. Feldmann, G. Ahlenstiel, B. Langhans, T. Sauerbruch, and U. Spengler. 2006. Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C. Gut 55:869-877.
30. Nattermann, J., H. D. Nischalke, V. Hofmeister, G. Ahlenstiel, H. Zimmermann, L. Leifeld, E. H. Weiss, T. Sauerbruch, and U. Spengler. 2005. The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells. Am. J. Pathol. 166:443-453.
31. Ortaldo, J. R., R. T. Winkler-Pickett, H. Yagita, and H. A. Young. 1991. Comparative studies of CD3- and CD3+ CD56+ cells: examination of morphology, functions, T cell receptor rearrangement, and pore-forming protein expression. Cell. Immunol. 136:486-495.
32. Palmieri, G., V. Tullio, A. Zingoni, M. Piccoli, L. Frati, M. Lopez-Botet, and A. Santoni. 1999. CD94/NKG2-A inhibitory complex blocks CD16-triggered Syk and extracellular regulated kinase activation, leading to cytotoxic function of human NK cells. J. Immunol. 162:7181-7188.
33. Pittet, M. J., D. E. Speiser, D. Valmori, J. C. Cerottini, and P. Romero. 2000. Cutting edge: cytolytic effector function in human circulating CD8+ T cells closely correlates with CD56 surface expression. J. Immunol. 164:1148-1152.
34. Semmo, N., C. L. Day, S. M. Ward, M. Lucas, G. Harcourt, A. Loughry, and P. Klenerman. 2005. Preferential loss of IL-2-secreting CD4+ T helper cells in chronic HCV infection. Hepatology 41:1019-1028.
35. Shilling, H. G., N. Young, L. A. Guethlein, N. W. Cheng, C. M. Gardiner, D. Tyan, and P. Parham. 2002. Genetic control of human NK cell repertoire. J. Immunol. 169:239-247.
36. Smyk-Pearson, S., I. A. Tester, D. Lezotte, A. W. Sasaki, D. M. Lewinsohn, and H. R. Rosen. 2006. Differential antigenic hierarchy associated with spontaneous recovery from hepatitis C virus infection: implications for vaccine design. J. Infect. Dis. 194:454-463.
37. Takehara, T., and N. Hayashi. 2005. Natural killer cells in hepatitis C virus infection: from innate immunity to adaptive immunity. Clin. Gastroenterol. Hepatol. 3:S78-S81.
38. Ullum, H., A. C. Lepri, H. Aladdin, T. Katzenstein, J. Victor, A. N. Phillips, J. Gerstoft, P. Skinhoj, and B. K. Pedersen. 1999. Natural immunity and HIV disease progression. AIDS 13:557-563.